https://www.delawarehealthnewsonline.com/article/912351771-cosciens-biopharma-inc-reports-q1-2026-results Delaware Health News Online en PressRelease 2026-05-12T21:05:00+00:00 COSCIENS Biopharma Inc. Reports Q1 2026 Results https://ml.globenewswire.com/media/703faafa-78e2-4d67-be2a-457eb4f57340/small/picture2-png.png https://www.delawarehealthnewsonline.com/article/912351774-bbot-reports-first-quarter-2026-financial-results-and-update-on-corporate-progress Delaware Health News Online en PressRelease 2026-05-12T21:03:31+00:00 BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://www.delawarehealthnewsonline.com/article/912350660-sanuwave-announces-revenues-and-financial-results-for-q1-fy2026 Delaware Health News Online en PressRelease 2026-05-12T21:00:00+00:00 Sanuwave Announces Revenues and Financial Results for Q1 FY2026 https://ml.globenewswire.com/media/6e709528-90af-4ff5-a08a-c0ea5a2cd4ab/small/sanuwave-logo-002-png.png https://www.delawarehealthnewsonline.com/article/912351557-eupraxia-pharmaceuticals-reports-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-12T21:00:00+00:00 Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg https://www.delawarehealthnewsonline.com/article/912350513-dbv-technologies-to-participate-in-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq Delaware Health News Online en PressRelease 2026-05-12T20:30:00+00:00 DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq https://ml-eu.globenewswire.com/media/274bd0ae-19c4-4821-85ce-7fe85ee610b5/small/logo1-jpg.jpg https://www.delawarehealthnewsonline.com/article/912350534-dbv-technologies-participera-la-4e-dition-de-la-conf-rence-annuelle-bioconnect-investor-organis-e-par-h-c-wainwright-au-nasdaq Delaware Health News Online en PressRelease 2026-05-12T20:30:00+00:00 DBV Technologies participera à la 4e édition de la conférence annuelle BioConnect Investor organisée par H.C. Wainwright au Nasdaq https://ml-eu.globenewswire.com/media/274bd0ae-19c4-4821-85ce-7fe85ee610b5/small/ https://www.delawarehealthnewsonline.com/article/912350602-innovage-appoints-jennifer-browne-as-president-and-chief-operating-officer Delaware Health News Online en PressRelease 2026-05-12T20:30:00+00:00 InnovAge Appoints Jennifer Browne as President and Chief Operating Officer https://ml.globenewswire.com/media/a1b976fe-053f-43be-b43c-532393a7f314/small/inn-logotag-rgb-jpg.jpg https://www.delawarehealthnewsonline.com/article/912350606-eton-pharmaceuticals-to-participate-in-upcoming-investor-conferences Delaware Health News Online en PressRelease 2026-05-12T20:30:00+00:00 Eton Pharmaceuticals to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png https://www.delawarehealthnewsonline.com/article/912350974-tonix-pharmaceuticals-to-participate-in-two-investor-conferences-in-may Delaware Health News Online en PressRelease 2026-05-12T20:30:00+00:00 Tonix Pharmaceuticals to Participate in Two Investor Conferences in May https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://www.delawarehealthnewsonline.com/article/912351067-alignment-healthcare-strengthens-leadership-team-to-support-long-term-growth-and-shareholder-value-creation Delaware Health News Online en PressRelease 2026-05-12T20:30:00+00:00 Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation https://ml.globenewswire.com/media/c6122501-032d-4425-bb0d-759ee3d3fe68/small/alignmenthealthcare-primary-logo-verticala-png.png https://www.delawarehealthnewsonline.com/article/912351138-crescent-biopharma-announces-grants-of-inducement-awards Delaware Health News Online en PressRelease 2026-05-12T20:30:00+00:00 Crescent Biopharma Announces Grants of Inducement Awards https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://www.delawarehealthnewsonline.com/article/912327817-orchestra-biomed-reports-first-quarter-2026-financial-results-and-highlights-recent-business-updates Delaware Health News Online en PressRelease 2026-05-12T20:18:12+00:00 Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://www.delawarehealthnewsonline.com/article/912350573-palisade-bio-reports-first-quarter-2026-financial-results-and-highlights-continued-clinical-progress-of-pali-2108 Delaware Health News Online en PressRelease 2026-05-12T20:15:00+00:00 Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108 https://ml.globenewswire.com/media/0beaede8-1c7c-4f77-84a7-b1efd54c343c/small/logo-png.png https://www.delawarehealthnewsonline.com/article/912351026-anaptys-announces-first-quarter-2026-financial-results-and-provides-business-update Delaware Health News Online en PressRelease 2026-05-12T20:15:00+00:00 Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://www.delawarehealthnewsonline.com/article/912351155-spectral-ai-announces-2026-first-quarter-financial-results Delaware Health News Online en PressRelease 2026-05-12T20:10:00+00:00 Spectral AI Announces 2026 First Quarter Financial Results https://ml.globenewswire.com/media/e51098e6-329d-4efc-acb5-a92a6b8f2a5d/small/spectral-ai-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912351195-solid-biosciences-reports-first-quarter-2026-financial-results-and-provides-business-updates Delaware Health News Online en PressRelease 2026-05-12T20:08:21+00:00 Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png https://www.delawarehealthnewsonline.com/article/912351177-interpace-biosciences-announces-first-quarter-2026-financial-and-business-results Delaware Health News Online en PressRelease 2026-05-12T20:06:19+00:00 Interpace Biosciences Announces First Quarter 2026 Financial and Business Results https://ml.globenewswire.com/media/b8fe939f-066b-4977-83f6-13d975b7c4e7/small/interpacebiosciences-new-logo-png.png https://www.delawarehealthnewsonline.com/article/912350683-stereotaxis-reports-2026-first-quarter-financial-results-business-updates Delaware Health News Online en PressRelease 2026-05-12T20:06:00+00:00 Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates https://ml.globenewswire.com/media/95a5b8ca-b7c0-4c80-8ca7-063ef10706c3/small/stereotaxis-logo-new-tagline-black-text-png.png https://www.delawarehealthnewsonline.com/article/912327091-nyxoah-reports-first-quarter-2026-financial-and-operating-results Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Nyxoah Reports First Quarter 2026 Financial and Operating Results https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/logo-nyxoah-rgb-png.png https://www.delawarehealthnewsonline.com/article/912327126-nyxoah-publie-ses-r-sultats-financiers-et-op-rationnels-du-premier-trimestre-2026 Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Nyxoah Publie ses Résultats Financiers et Opérationnels du Premier Trimestre 2026 https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/ https://www.delawarehealthnewsonline.com/article/912327130-lb-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-corporate-update Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/90903161-520e-409f-b2ac-dd18677b4bb8/small/lb-pharma-logo-png.png https://www.delawarehealthnewsonline.com/article/912327153-connect-biopharma-to-present-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference https://ml.globenewswire.com/media/831dcc2a-691d-4cad-813e-855f9fa2bd69/small/connect-logo-cmyk-jpg.jpg https://www.delawarehealthnewsonline.com/article/912327182-bolt-biotherapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/fb5e6ce9-fbe4-4a9b-a822-dac88f68c979/small/bolt-logo-png.png https://www.delawarehealthnewsonline.com/article/912327192-nurix-therapeutics-announces-bexobrutideg-oral-presentation-at-the-2026-european-hematology-association-congress Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress https://ml.globenewswire.com/media/65f50366-0a4e-4329-b0f5-f737c6145524/small/new-primary-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912327197-surrozen-to-present-at-upcoming-healthcare-investor-conference Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Surrozen to Present at Upcoming Healthcare Investor Conference https://ml.globenewswire.com/media/f8766f36-378a-41ad-9256-3cf0ca847440/small/logoonly-png.png https://www.delawarehealthnewsonline.com/article/912327201-bridgebio-oncology-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://www.delawarehealthnewsonline.com/article/912327210-neumora-therapeutics-to-participate-in-2026-rbc-capital-markets-global-healthcare-conference Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912327213-fractyl-health-reports-first-quarter-2026-financial-results-and-business-updates Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates https://ml.globenewswire.com/media/3a379315-9c07-4655-883e-7e7f26c67778/small/fractyl-logo-png.png https://www.delawarehealthnewsonline.com/article/912327283-pharvaris-reports-first-quarter-2026-financial-results-and-provides-business-update Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://www.delawarehealthnewsonline.com/article/912327299-rezolute-reports-third-quarter-fiscal-2026-financial-results-and-provides-business-update Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/bbe03de3-6870-4230-b875-d8965a3d1b97/small/rezolute-jpg.jpg https://www.delawarehealthnewsonline.com/article/912327333-atea-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png https://www.delawarehealthnewsonline.com/article/912327349-zentalis-pharmaceuticals-reports-first-quarter-2026-financial-results-and-clinical-progress Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress https://ml.globenewswire.com/media/ecb98bea-7a9f-4319-874c-1911777a5a46/small/zentalis-logo-full-color-png.png https://www.delawarehealthnewsonline.com/article/912327370-sellas-life-sciences-reports-first-quarter-2026-financial-results-and-provides-corporate-update Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/4ff07596-ddcc-4df5-be2f-e31a35217739/small/sellas-logo-png.png https://www.delawarehealthnewsonline.com/article/912327406-biostem-technologies-to-present-at-the-16th-annual-ld-micro-invitational Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 BioStem Technologies to Present at the 16th Annual LD Micro Invitational https://ml.globenewswire.com/media/da0ea21a-fd6e-425a-a8f2-6f69dc2b4612/small/biostem-main-logo-png.png https://www.delawarehealthnewsonline.com/article/912327423-rani-therapeutics-to-participate-in-the-h-c-wainwright-annual-bioconnect-investor-conference Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference https://ml.globenewswire.com/media/8ce7774c-3696-4aa1-8bcd-413805f0a642/small/rani-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912327427-jushi-holdings-inc-reports-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Jushi Holdings Inc. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/e65f15fd-322c-4847-83c5-ceafe27f97d5/small/jushi-png.png https://www.delawarehealthnewsonline.com/article/912327440-gyre-therapeutics-announces-nmpa-acceptance-of-new-drug-application-for-f351-hydronidone-for-chb-induced-liver-fibrosis-treatment Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment https://ml.globenewswire.com/media/24951768-57e9-4d7a-b969-f00258b17136/small/gyre-logo-png.png https://www.delawarehealthnewsonline.com/article/912327446-relmada-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/8a986b0a-11c8-4551-b0ad-ec20fe2fe40a/small/relmada-logo-png.png https://www.delawarehealthnewsonline.com/article/912327452-damora-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights https://ml.globenewswire.com/media/547722cf-495b-4464-97a9-35bea3fa5d15/small/damora-rgb-png.png https://www.delawarehealthnewsonline.com/article/912327461-tela-bio-reports-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 TELA Bio Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/62aad9be-813a-415e-990b-f27442cbec50/small/download-png.png https://www.delawarehealthnewsonline.com/article/912327474-maxcyte-reports-first-quarter-2026-financial-results-and-reiterates-full-year-2026-guidance Delaware Health News Online en PressRelease 2026-05-12T20:05:00+00:00 MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 Guidance https://ml.globenewswire.com/media/8f0f0d48-fc4f-4d03-ac70-f4d096a780bd/small/maxcyte-logo-600x600-png.png https://www.delawarehealthnewsonline.com/article/912327359-kyverna-therapeutics-announces-initiation-of-rolling-sps-bla-submission-and-reports-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-12T20:02:00+00:00 Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.delawarehealthnewsonline.com/article/912327431-kura-oncology-reports-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-12T20:02:00+00:00 Kura Oncology Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.delawarehealthnewsonline.com/article/912327168-aura-biosciences-to-participate-in-upcoming-investor-conferences Delaware Health News Online en PressRelease 2026-05-12T20:01:00+00:00 Aura Biosciences to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.delawarehealthnewsonline.com/article/912327228-inhibikase-therapeutics-announces-first-quarter-2026-financial-results-and-highlights-recent-activity Delaware Health News Online en PressRelease 2026-05-12T20:01:00+00:00 Inhibikase Therapeutics Announces First Quarter 2026 Financial Results and Highlights Recent Activity https://ml.globenewswire.com/media/32b8d8bc-ebf8-43c0-866a-6613b22263b1/small/ikt-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912327364-verrica-pharmaceuticals-reports-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-12T20:01:00+00:00 Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912327442-pacira-biosciences-sends-letter-to-stockholders-reiterating-superior-qualifications-of-its-board-nominees Delaware Health News Online en PressRelease 2026-05-12T20:01:00+00:00 Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://www.delawarehealthnewsonline.com/article/912327638-nkarta-reports-first-quarter-2026-financial-results-and-corporate-highlights Delaware Health News Online en PressRelease 2026-05-12T20:01:00+00:00 Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights https://ml.globenewswire.com/media/09e7df7f-9555-45c9-bef1-86131c859ed3/small/nkarta-logo-2022-jpg.jpg https://www.delawarehealthnewsonline.com/article/912327713-maze-therapeutics-reports-first-quarter-2026-financial-results-and-recent-highlights Delaware Health News Online en PressRelease 2026-05-12T20:01:00+00:00 Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights https://ml.globenewswire.com/media/20759f53-8fbe-4af8-9fc1-3a4a4ac5c195/small/lol-png.png https://www.delawarehealthnewsonline.com/article/912327456-cytokinetics-to-participate-in-the-2026-rbc-capital-markets-global-healthcare-conference Delaware Health News Online en PressRelease 2026-05-12T20:00:00+00:00 Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.delawarehealthnewsonline.com/article/912304549-the-25th-tunnel-to-towers-nyc-5k-run-walk-is-set-for-september-27th Delaware Health News Online en PressRelease 2026-05-12T17:58:10+00:00 The 25th Tunnel to Towers NYC 5K Run & Walk is Set for September 27th https://ml.globenewswire.com/media/NDYwYWU5NTAtODg3Yi00MzQ5LTllZDktMGQzODc5YTQ3YjUwLTExMzQ0NDMtMjAyNi0wNS0xMi1lbg==/tiny/Stephen-Siller-Tunnel-To-Tower.png https://www.delawarehealthnewsonline.com/article/912304451-update-skye-bioscience-reports-first-quarter-2026-financial-results-and-business-update Delaware Health News Online en PressRelease 2026-05-12T17:33:53+00:00 UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update https://ml.globenewswire.com/media/905e06d8-af43-4f7a-b097-8c12ce1d3aa0/small/skye-darkblue-jpg.jpg https://www.delawarehealthnewsonline.com/article/912282903-recordati-strong-momentum-of-the-group-continues-into-the-first-quarter-of-2026-net-revenue-4-9-ebitda-1-5-0-adjusted-net-income-2-7-2 Delaware Health News Online en PressRelease 2026-05-12T16:46:39+00:00 RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2% https://ml-eu.globenewswire.com/media/a64917fc-da51-47f4-a36a-dc04b029ed8b/small/r-logo2023-rgb-3-png.png https://www.delawarehealthnewsonline.com/article/912282909-recordati-il-forte-slancio-del-gruppo-prosegue-nel-primo-trimestre-del-2026-ricavi-netti-4-9-ebitda-1-5-0-utile-netto-rettificato-2-7-2 Delaware Health News Online en PressRelease 2026-05-12T16:46:39+00:00 RECORDATI: IL FORTE SLANCIO DEL GRUPPO PROSEGUE NEL PRIMO TRIMESTRE DEL 2026 RICAVI NETTI +4,9%, EBITDA(1) +5,0%, UTILE NETTO RETTIFICATO(2) +7,2% https://ml-eu.globenewswire.com/media/e91474c3-cf48-41ba-ba26-b56e8278779f/small/r-logo2023-rgb-3-png.png https://www.delawarehealthnewsonline.com/article/912283056-to-your-health-launches-innovative-online-protein-intake-calculator Delaware Health News Online en PressRelease 2026-05-12T16:42:00+00:00 To Your Health Launches Innovative Online Protein Intake Calculator https://ml.globenewswire.com/media/08b8a73d-cd8f-4090-9c45-b598e5c48df4/small/to-your-health-logo.png https://www.delawarehealthnewsonline.com/article/912283060-atum-s-new-lock-in-platform-solves-bispecific-mispairing Delaware Health News Online en PressRelease 2026-05-12T16:37:00+00:00 ATUM’s New Lock-In Platform Solves Bispecific Mispairing https://ml.globenewswire.com/media/874d4e0a-920f-43ea-b167-d50dc78bc154/small/atum-logo.png https://www.delawarehealthnewsonline.com/article/912283027-sacramento-kings-and-sutter-health-announce-strategic-partnership Delaware Health News Online en PressRelease 2026-05-12T16:30:00+00:00 Sacramento Kings and Sutter Health Announce Strategic Partnership https://ml.globenewswire.com/media/MWIwNDMwZmMtODk1OS00MDdhLTk3NmYtOTYzMDM4NmEyM2JlLTUwMDE1MDYxNS0yMDI2LTA1LTEyLWVu/tiny/Sutter-Health.png https://www.delawarehealthnewsonline.com/article/912282882-high-diet-surpasses-1-700-customer-reviews-as-users-praise-personalized-high-protein-meal-plans Delaware Health News Online en PressRelease 2026-05-12T16:09:57+00:00 High Diet Surpasses 1,700 Customer Reviews as Users Praise Personalized High-Protein Meal Plans https://ml-eu.globenewswire.com/media/8189e2bb-1b29-42e3-8d37-b550802925ee/medium/high-diet.png https://www.delawarehealthnewsonline.com/article/912283071-tevogen-announces-3-million-private-investment-at-8-per-share-a-14-premium-from-latest-market-close Delaware Health News Online en PressRelease 2026-05-12T15:45:00+00:00 Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close https://ml.globenewswire.com/media/679fef4d-f32f-46a2-9452-c31af5cf4597/small/tevogen-logo-newswire-png.png https://www.delawarehealthnewsonline.com/article/912263202-american-urological-association-releases-advanced-prostate-cancer-guideline-amendment Delaware Health News Online en PressRelease 2026-05-12T14:55:21+00:00 American Urological Association Releases Advanced Prostate Cancer Guideline Amendment https://ml.globenewswire.com/media/N2FjMTc1MjQtMGNjMS00MjYyLWFjMWEtNjliYjViOTAwNDI1LTEyNzYxOTAtMjAyNi0wNS0xMi1lbg==/tiny/American-Urological-Associatio.png https://www.delawarehealthnewsonline.com/article/912263125-syndax-highlights-12-revuforj-revumenib-abstracts-accepted-for-eha-2026-advancing-leadership-in-menin-inhibition Delaware Health News Online en PressRelease 2026-05-12T14:31:49+00:00 Syndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912262512-global-urinalysis-market-set-to-reach-usd-6-81-billion-by-2029-marketsandmarkets Delaware Health News Online en PressRelease 2026-05-12T14:30:00+00:00 Global Urinalysis Market Set to Reach USD 6.81 Billion by 2029 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.delawarehealthnewsonline.com/article/912263115-nexgel-to-report-first-quarter-2026-financial-results-on-may-15th Delaware Health News Online en PressRelease 2026-05-12T14:27:00+00:00 NEXGEL To Report First Quarter 2026 Financial Results on May 15th https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://www.delawarehealthnewsonline.com/article/912263057-extendicare-files-business-acquisition-report-in-connection-with-the-cbi-home-health-acquisition Delaware Health News Online en PressRelease 2026-05-12T14:06:34+00:00 Extendicare Files Business Acquisition Report in connection with the CBI Home Health Acquisition https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://www.delawarehealthnewsonline.com/article/912262575-telespecialists-expands-digital-healthcare-access-across-rural-communities-nationwide Delaware Health News Online en PressRelease 2026-05-12T14:00:00+00:00 TeleSpecialists Expands Digital Healthcare Access Across Rural Communities Nationwide https://ml.globenewswire.com/media/Nzc2ZWNlNjctOGI3Yi00MTVmLWExYWItOGJlN2E3YmMwMDQ3LTUwMDE0OTY0OS0yMDI2LTA1LTEyLWVu/tiny/TeleSpecialists.png https://www.delawarehealthnewsonline.com/article/912262649-truveta-and-knit-health-announce-collaboration-to-power-a-new-generation-of-clinical-ai Delaware Health News Online en PressRelease 2026-05-12T14:00:00+00:00 Truveta and Knit Health announce collaboration to power a new generation of clinical AI https://ml.globenewswire.com/media/NmQ2OWNjNTYtNTgwMy00YjI0LTlmYWMtZTQzYzkzM2YxMmNmLTEyNzUzNzQtMjAyNi0wNS0xMi1lbg==/tiny/Truveta.png https://www.delawarehealthnewsonline.com/article/912262678-liveworld-s-new-app-research-council-gives-brands-direct-access-to-frontline-np-and-pa-insights-to-improve-relevance-reach-and-roi Delaware Health News Online en PressRelease 2026-05-12T14:00:00+00:00 LiveWorld's New APP Research Council Gives Brands Direct Access to Frontline NP and PA Insights to Improve Relevance, Reach, and ROI https://ml.globenewswire.com/media/b26faeda-6846-4308-830c-e53ab023ba65/small/liveworld-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912263003-mental-health-awareness-month-tpn-health-solves-the-access-crisis-costing-self-insured-stakeholders-health-plans-and-members-the-care-they-deserve Delaware Health News Online en PressRelease 2026-05-12T14:00:00+00:00 Mental Health Awareness Month: TPN.health Solves the Access Crisis Costing Self-Insured Stakeholders, Health Plans and Members the Care They Deserve https://ml.globenewswire.com/media/7f287fef-0e9e-4b21-b184-be4db60a5c50/small/tpn-health-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912262589-becker-s-names-leap-distributors-ceo-allen-mason-to-2026-great-leaders-in-healthcare-list Delaware Health News Online en PressRelease 2026-05-12T13:47:00+00:00 Becker’s Names Leap Distributors CEO Allen Mason to 2026 Great Leaders in Healthcare List https://ml.globenewswire.com/media/NjA3MGZmNGUtMzA4NS00ZTMwLTlhMzItYjBmN2E4ODQ0ZGY1LTEzMDY0NDctMjAyNi0wNS0xMi1lbg==/tiny/Leap-Distributors.png https://www.delawarehealthnewsonline.com/article/912262938-kura-oncology-and-kyowa-kirin-to-present-updated-frontline-ziftomenib-7-3-combination-data-at-eha-2026-congress Delaware Health News Online en PressRelease 2026-05-12T13:40:16+00:00 Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.delawarehealthnewsonline.com/article/912245475-aquestive-therapeutics-completes-150-million-debt-refinancing-with-oaktree Delaware Health News Online en PressRelease 2026-05-12T13:31:25+00:00 Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree https://ml.globenewswire.com/media/e0b65f93-9565-43d7-a6ff-88b8cbd6adea/small/aquestive-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244503-agios-submits-snda-to-fda-for-u-s-accelerated-approval-of-mitapivat-in-sickle-cell-disease Delaware Health News Online en PressRelease 2026-05-12T13:31:00+00:00 Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png https://www.delawarehealthnewsonline.com/article/912245337-first-real-world-evidence-study-of-rytelo-imetelstat-in-lower-risk-myelodysplastic-syndromes-lr-mds-to-be-presented-at-eha-2026 Delaware Health News Online en PressRelease 2026-05-12T13:31:00+00:00 First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026  https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912243550-evaxion-to-present-new-data-for-evx-04-an-off-the-shelf-therapeutic-vaccine-for-acute-myeloid-leukemia-at-the-eha-2026-congress Delaware Health News Online en PressRelease 2026-05-12T13:30:00+00:00 Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://www.delawarehealthnewsonline.com/article/912244021-beam-therapeutics-to-present-updated-biomarker-data-from-phase-1-2-beacon-trial-further-underscoring-risto-cel-s-ability-to-restore-red-blood-cell Delaware Health News Online en PressRelease 2026-05-12T13:30:00+00:00 Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026 https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244194-cogent-biosciences-announces-multiple-presentations-at-the-european-hematology-association-eha-2026-congress Delaware Health News Online en PressRelease 2026-05-12T13:30:00+00:00 Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://www.delawarehealthnewsonline.com/article/912244306-disc-medicine-announces-multiple-presentations-across-portfolio-at-the-european-hematology-association-eha-2026-congress Delaware Health News Online en PressRelease 2026-05-12T13:30:00+00:00 Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244316-caribou-biosciences-to-highlight-vispa-cel-and-cb-011-programs-during-oral-presentations-at-the-2026-european-hematology-association-eha-annual Delaware Health News Online en PressRelease 2026-05-12T13:30:00+00:00 Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting https://ml.globenewswire.com/media/9cd3169e-5a07-44f7-b820-b6f4fff6e4d1/small/caribou-logo-png.png https://www.delawarehealthnewsonline.com/article/912244517-blossomhill-therapeutics-to-present-initial-clinical-dose-escalation-data-from-the-phase-1-1b-trial-of-bh-30236-in-patients-with-r-r-aml-or-hr-mds-at Delaware Health News Online en PressRelease 2026-05-12T13:30:00+00:00 BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026 https://ml.globenewswire.com/media/02f747e9-636d-467e-81f8-d942e9421158/small/blossomhill-vertical-fullcolor-cmyk1-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244522-agios-to-present-new-data-at-eha-2026-reinforcing-the-significant-therapeutic-impact-of-mitapivat-across-multiple-rare-hemolytic-anemias Delaware Health News Online en PressRelease 2026-05-12T13:30:00+00:00 Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png https://www.delawarehealthnewsonline.com/article/912244899-ajax-therapeutics-announces-oral-presentation-of-clinical-results-from-ajx-101-a-phase-i-study-of-aj1-11095-a-first-in-class-type-ii-jak2-inhibitor Delaware Health News Online en PressRelease 2026-05-12T13:30:00+00:00 Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress https://ml.globenewswire.com/media/4a1616ad-5fbb-4df2-8270-094f5294c667/small/ajax-gradient-logo-rgb-large-png.png https://www.delawarehealthnewsonline.com/article/912245006-cellectis-to-present-clinical-data-on-lasme-cel-and-eti-cel-at-eha-2026-annual-congress Delaware Health News Online en PressRelease 2026-05-12T13:30:00+00:00 Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.delawarehealthnewsonline.com/article/912245010-cellectis-pr-sentera-des-donn-es-cliniques-sur-lasm-cel-et-ti-cel-au-congr-s-annuel-de-l-eha-2026 Delaware Health News Online en PressRelease 2026-05-12T13:30:00+00:00 Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.delawarehealthnewsonline.com/article/912245263-independent-cleveland-clinic-review-finds-no-clinically-significant-cardiotoxicity-with-moleculin-s-annamycin-in-r-r-aml-patients-dosed-beyond Delaware Health News Online en PressRelease 2026-05-12T13:30:00+00:00 Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://www.delawarehealthnewsonline.com/article/912244197-payzen-report-healthcare-financial-pressures-mount-as-73-of-systems-elevate-patient-payment-balances-to-a-top-priority Delaware Health News Online en PressRelease 2026-05-12T13:15:00+00:00 PayZen Report: Healthcare Financial Pressures Mount as 73% of Systems Elevate Patient Payment Balances to a Top Priority https://ml.globenewswire.com/media/22679992-a395-40a3-9e05-2da99e869af5/small/payzen-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244812-four-winners-selected-in-perfectserve-s-2026-nurses-of-note-awards-program Delaware Health News Online en PressRelease 2026-05-12T13:05:00+00:00 Four Winners Selected in PerfectServe’s 2026 Nurses of Note Awards Program https://ml.globenewswire.com/media/3a42b331-2462-49bf-8760-8ac24410cc52/medium/winners-announced-for-perfectserve-s-2026-nurses-of-note-awa.jpg https://www.delawarehealthnewsonline.com/article/912244237-ontra-launches-ai-powered-ddq-solution-to-accelerate-investor-diligence-for-private-markets-firms Delaware Health News Online en PressRelease 2026-05-12T13:02:00+00:00 Ontra Launches AI-Powered DDQ Solution to Accelerate Investor Diligence for Private Markets Firms https://ml.globenewswire.com/media/ea2f73c7-a69a-43fc-a08c-0aa1239f582e/small/ontra-horizontal-black-1-png.png https://www.delawarehealthnewsonline.com/article/912243624-resolution-therapeutics-to-showcase-key-preclinical-data-on-its-regenerative-macrophage-therapy-rmt-rtx001-in-oral-presentation-at-asgct-2026 Delaware Health News Online en PressRelease 2026-05-12T13:00:00+00:00 Resolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026 https://ml-eu.globenewswire.com/media/9482740b-de8b-45a4-b278-7f5f9c3797c0/small/high-resolution-logo-png.png https://www.delawarehealthnewsonline.com/article/912244008-jenavalve-appoints-dave-haan-as-vice-president-of-clinical-affairs Delaware Health News Online en PressRelease 2026-05-12T13:00:00+00:00 JenaValve Appoints Dave Haan as Vice President of Clinical Affairs https://ml.globenewswire.com/media/a1ab2446-a463-4b8f-bc18-26a5ca117176/small/jv-logo-h-rgb-l-1607-png.png https://www.delawarehealthnewsonline.com/article/912244218-muscular-dystrophy-association-announces-100-000-investment-to-advance-lgmd-care-at-leading-mda-care-centers-with-bridgebio Delaware Health News Online en PressRelease 2026-05-12T13:00:00+00:00 Muscular Dystrophy Association Announces $100,000 Investment to Advance LGMD Care at Leading MDA Care Centers with BridgeBio https://ml.globenewswire.com/media/ZGM3NWNhNjUtZWY5My00OGEwLWJjYWUtZGEyNjViOWZjNDdjLTEwOTg0NjYtMjAyNi0wNS0xMi1lbg==/tiny/Muscular-Dystrophy-Association.png https://www.delawarehealthnewsonline.com/article/912244310-connect-biopharma-reports-first-quarter-2026-financial-results-and-provides-business-update Delaware Health News Online en PressRelease 2026-05-12T13:00:00+00:00 Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/831dcc2a-691d-4cad-813e-855f9fa2bd69/small/connect-logo-cmyk-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244539-liveworld-reports-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-12T13:00:00+00:00 LiveWorld Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/b26faeda-6846-4308-830c-e53ab023ba65/small/liveworld-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244912-prognomiq-announces-breakthrough-results-for-the-early-detection-of-lung-cancer-in-ongoing-real-world-study-for-its-novel-blood-test Delaware Health News Online en PressRelease 2026-05-12T13:00:00+00:00 PrognomiQ Announces Breakthrough Results for the Early Detection of Lung Cancer in Ongoing Real-World Study for Its Novel Blood Test https://ml.globenewswire.com/media/96409eec-09cb-41f0-af6f-66ec52af7f62/small/prognomiq-logo-rgb-jpg.jpg https://www.delawarehealthnewsonline.com/article/912245065-clearmind-medicine-reaches-important-clinical-milestone-20-participants-now-treated-in-ongoing-phase-i-iia-trial-of-cmnd-100-for-alcohol-use-disorder Delaware Health News Online en PressRelease 2026-05-12T12:41:00+00:00 Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244802-fortis-life-sciences-awards-2026-abnano-vhh-discovery-grant-to-deliver-biosciences-for-targeted-drug-delivery-research Delaware Health News Online en PressRelease 2026-05-12T12:40:00+00:00 Fortis Life Sciences Awards 2026 AbNano® VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery Research https://ml.globenewswire.com/media/35b82fbc-92f2-41d4-abbb-3a83618a33b7/small/fortis-logo-purple-png.png https://www.delawarehealthnewsonline.com/article/912243815-envue-medical-secures-three-year-contract-renewal-at-12-hospital-u-s-health-network-as-the-envue-navigation-platform-becomes-standard-of-care Delaware Health News Online en PressRelease 2026-05-12T12:37:00+00:00 ENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue™ Navigation Platform Becomes Standard of Care https://ml.globenewswire.com/media/e0a97028-a7c3-4dd6-a13f-a55e43617883/small/logo-small-722-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244004-akari-therapeutics-secures-key-european-patent-for-its-novel-rna-splicing-modulator-adc-payload-strengthening-global-ip-estate-for-all-major-global Delaware Health News Online en PressRelease 2026-05-12T12:33:00+00:00 Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244201-20-20-biolabs-exclusively-licenses-psa-velocity-algorithm-from-the-university-of-south-carolina Delaware Health News Online en PressRelease 2026-05-12T12:31:00+00:00 20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina https://ml.globenewswire.com/media/bcaf95ca-9983-408c-bc61-646e4ee2f925/small/2020-biolabs-logo-png.png https://www.delawarehealthnewsonline.com/article/912243861-adagene-to-participate-in-two-upcoming-investor-conferences Delaware Health News Online en PressRelease 2026-05-12T12:30:00+00:00 Adagene to Participate in Two Upcoming Investor Conferences https://ml.globenewswire.com/media/c377318b-edf7-42c0-8e7c-63a02bbe47b0/small/adagene-logo-gnw-png.png https://www.delawarehealthnewsonline.com/article/912244371-lexicon-pharmaceuticals-to-present-at-the-4th-annual-h-c-wainwright-bioconnect-investor-conference Delaware Health News Online en PressRelease 2026-05-12T12:30:00+00:00 Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244725-orchestra-biomed-targeting-backbeat-trial-enrollment-completion-by-end-of-q3-2026-and-data-presentation-in-q2-2027 Delaware Health News Online en PressRelease 2026-05-12T12:30:00+00:00 Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027 https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://www.delawarehealthnewsonline.com/article/912244831-oncotelic-therapeutics-inc-otcqb-otlc-proprietary-n2b-system-may-offer-key-to-unlocking-next-gen-therapies Delaware Health News Online en PressRelease 2026-05-12T12:30:00+00:00 Oncotelic Therapeutics Inc. (OTCQB: OTLC) Proprietary N2B System May Offer Key to Unlocking Next-Gen Therapies https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244942-mindbio-therapeutics-corp-cse-mbio-otcqb-mbqif-leveraging-ai-voice-analysis-to-develop-intoxication-detection Delaware Health News Online en PressRelease 2026-05-12T12:30:00+00:00 MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Leveraging AI, Voice Analysis to Develop Intoxication Detection https://ml.globenewswire.com/media/ef429fe7-9cc2-4785-8e91-97fe534a4cd1/small/mbio-2048x537-png.png https://www.delawarehealthnewsonline.com/article/912244950-surenano-science-ltd-cse-sure-otcqb-surnf-advancing-a-differentiated-next-gen-glp-1-platform Delaware Health News Online en PressRelease 2026-05-12T12:30:00+00:00 SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform https://ml.globenewswire.com/media/4e983dfa-f169-46a5-ba21-ed1d05a90830/small/surenano-logo-png.png https://www.delawarehealthnewsonline.com/article/912243561-boehringer-ingelheim-licenses-preclinical-antibody-program-from-immunitas-therapeutics-to-advance-treatments-for-chronic-inflammatory-diseases Delaware Health News Online en PressRelease 2026-05-12T12:05:00+00:00 Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://www.delawarehealthnewsonline.com/article/912244222-crb-project-honored-as-2026-ispe-facility-of-the-year-awards-winner Delaware Health News Online en PressRelease 2026-05-12T12:05:00+00:00 CRB Project Honored as 2026 ISPE Facility of the Year Awards Winner https://ml.globenewswire.com/media/ODdhNWE1YWYtYzhkMy00NzA3LTk0OWItNzE4Njk0MDhmNWM3LTUwMDEzMTU2Ni0yMDI2LTA1LTEyLWVu/tiny/CRB-Group-Inc-.png https://www.delawarehealthnewsonline.com/article/912243697-flyte-activates-high-frequency-preakness-flight-program-deploying-fleet-to-serve-strong-northeast-demand Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 FLYTE ACTIVATES HIGH-FREQUENCY PREAKNESS FLIGHT PROGRAM, DEPLOYING FLEET TO SERVE STRONG NORTHEAST DEMAND https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912243779-imunon-reports-first-quarter-2026-financial-results-and-provides-business-update Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 IMUNON Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/acf78e45-a45b-456b-93e3-0e39f2122826/small/logo-png.png https://www.delawarehealthnewsonline.com/article/912243822-invitria-presents-new-data-at-asgct-2026-on-recombinant-human-serum-albumin-for-higher-lentiviral-vector-titers-and-improved-cell-therapy Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 InVitria Presents New Data at ASGCT 2026 on Recombinant Human Serum Albumin for Higher Lentiviral Vector Titers and Improved Cell Therapy Manufacturing https://ml.globenewswire.com/media/a765699d-9866-4c97-be6f-7c3390501d12/small/invitria-logo-performance-defined-800-x-400-px-png.png https://www.delawarehealthnewsonline.com/article/912243932-opko-health-s-modex-therapeutics-will-present-data-demonstrating-in-vivo-car-t-cell-generation-and-deep-b-cell-depletion-in-preclinical-studies Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies https://ml.globenewswire.com/media/ed68aecb-6753-42d8-8b52-a6ec3e054b34/small/opko-png.png https://www.delawarehealthnewsonline.com/article/912243968-ascentage-pharma-to-participate-in-three-upcoming-investor-conferences Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Ascentage Pharma to Participate in Three Upcoming Investor Conferences https://ml.globenewswire.com/media/b9623a51-a13b-4b80-8152-61d5014f4a0a/small/2025-11-12-ascentage-600x600-png.png https://www.delawarehealthnewsonline.com/article/912244139-pmv-pharmaceuticals-reports-first-quarter-2026-financial-results-and-corporate-highlights Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights https://ml.globenewswire.com/media/856eb6a7-75a1-45e1-8b0e-e50c81bf0d62/small/pmv-logo-new-png.png https://www.delawarehealthnewsonline.com/article/912244178-cloudbreak-pharma-to-present-at-the-stifel-2026-virtual-ophthalmology-forum Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Cloudbreak Pharma to Present at the Stifel 2026 Virtual Ophthalmology Forum https://ml.globenewswire.com/media/a68e17c2-8a7a-44cf-bf9d-22382ad4109d/small/cloudbreak-pharma-logo-file-png.png https://www.delawarehealthnewsonline.com/article/912244216-sol-sence-reports-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Solésence Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/cd3e5e4e-9567-4a86-8f44-900ffeb29d33/small/solesence-fullcolor-300dpi-social-002-1-png.png https://www.delawarehealthnewsonline.com/article/912244299-corbus-pharmaceuticals-reports-q1-2026-financial-results-and-provides-a-corporate-update Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244347-rhythm-pharmaceuticals-announces-new-data-presentations-at-the-2026-european-congress-of-endocrinology Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244420-cerevance-completes-enrollment-in-pivotal-phase-3-parkinson-s-disease-trial-and-closes-oversubscribed-20-million-series-c-to-extend-runway-into-2027 Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027 https://ml.globenewswire.com/media/7b8bba27-38bb-484c-afef-fc5a539ec4e5/small/cerevance-logo-px-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244507-debra-hussain-joins-chiesi-usa-as-vice-president-and-business-unit-leader-u-s-care Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Debra Hussain Joins Chiesi USA as Vice President and Business Unit Leader, U.S. CARE https://ml.globenewswire.com/media/16391baf-8814-4a94-a863-8ac2f441d52b/small/chiesi-logo-1-primary-png.png https://www.delawarehealthnewsonline.com/article/912244655-lyell-immunopharma-announces-participation-in-may-investor-conferences Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Lyell Immunopharma Announces Participation in May Investor Conferences https://ml.globenewswire.com/media/fa4a7bb1-f8ea-45e7-ba51-37077689a4fb/small/lyell-branding-color-rgb-102918a-copy-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244823-gelteq-announces-usd-3-5-million-strategic-debt-financing-to-accelerate-commercialization-and-support-revenue-growth Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth https://ml.globenewswire.com/media/178e1a9c-f21e-4691-add7-b1398d96f7a6/small/gelteq-jpg.jpg https://www.delawarehealthnewsonline.com/article/912244826-ataibeckley-reports-first-quarter-2026-financial-results-and-provides-program-and-business-update Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update https://ml.globenewswire.com/media/cea08bf4-0562-45ed-af5c-c9376c48a6eb/small/ataibeckley-horizontal-2color-png.png https://www.delawarehealthnewsonline.com/article/912244837-humacyte-appoints-dr-todd-e-rasmussen-as-chief-surgical-officer Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Humacyte Appoints Dr. Todd E. Rasmussen as Chief Surgical Officer https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://www.delawarehealthnewsonline.com/article/912244843-positive-interim-phase-3-results-highlight-potential-of-ovaprene-novel-hormone-free-contraceptive Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive https://ml.globenewswire.com/media/deaaf9ba-24cc-4909-ab8d-1982b8b4e650/small/darebioscience-primarylogo-02-vertical-reg-orangebrown-wtrad.png https://www.delawarehealthnewsonline.com/article/912245000-brain-cancer-canada-awards-100-000-the-emily-mcintosh-brain-cancer-research-grant-to-advance-breakthrough-immunotherapy-for-glioblastoma Delaware Health News Online en PressRelease 2026-05-12T12:00:00+00:00 Brain Cancer Canada Awards $100,000 “The Emily McIntosh Brain Cancer Research Grant” to Advance Breakthrough Immunotherapy for Glioblastoma https://ml.globenewswire.com/media/78a73b7f-a470-42a5-9976-aa425939a68b/small/bcc-logo-2024-png.png https://www.delawarehealthnewsonline.com/article/912225800-mink-therapeutics-presents-clinical-evidence-that-a-single-off-the-shelf-inkt-cell-product-drives-context-dependent-immune-responses-at-asgct-2026 Delaware Health News Online en PressRelease 2026-05-12T11:35:30+00:00 MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026 https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://www.delawarehealthnewsonline.com/article/912225796-collegium-completes-acquisition-of-azstarys-from-corium-therapeutics Delaware Health News Online en PressRelease 2026-05-12T11:31:46+00:00 Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics https://ml.globenewswire.com/media/c9077b27-1a69-42a5-9f77-e39124f4d2a2/small/collegium-rgb-large-r-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225292-aveanna-to-participate-at-the-william-blair-46th-annual-growth-stock-conference Delaware Health News Online en PressRelease 2026-05-12T11:30:00+00:00 Aveanna to Participate at the William Blair 46th Annual Growth Stock Conference https://ml.globenewswire.com/media/d3896f9e-a6a1-48c1-a8f7-d9ba5d7433d6/small/aveanna-healthcare-500x262-png.png https://www.delawarehealthnewsonline.com/article/912225295-sab-bio-reports-q1-2026-financial-results-and-recent-business-highlights Delaware Health News Online en PressRelease 2026-05-12T11:30:00+00:00 SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/6d99a771-f2c9-4d05-bf57-4f6c070df032/small/sabprimarylogocolorrgb900px72ppi-png.png https://www.delawarehealthnewsonline.com/article/912225296-compass-therapeutics-to-participate-in-upcoming-may-investor-events Delaware Health News Online en PressRelease 2026-05-12T11:30:00+00:00 Compass Therapeutics to Participate in Upcoming May Investor Events https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png https://www.delawarehealthnewsonline.com/article/912225385-sagimet-biosciences-reports-first-quarter-2026-financial-results-and-provides-corporate-updates Delaware Health News Online en PressRelease 2026-05-12T11:30:00+00:00 Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://www.delawarehealthnewsonline.com/article/912225437-zevra-therapeutics-to-present-at-the-h-c-wainwright-bioconnect-investor-conference Delaware Health News Online en PressRelease 2026-05-12T11:30:00+00:00 Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference https://ml.globenewswire.com/media/cf39ab90-8c07-407d-a7ea-b7c9d48d44c4/small/zevra-inline-fullcolor-rgb-12in-300ppi-1-png.png https://www.delawarehealthnewsonline.com/article/912225444-mereo-biopharma-reports-first-quarter-2026-financial-results-and-provides-corporate-updates Delaware Health News Online en PressRelease 2026-05-12T11:30:00+00:00 Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates https://ml.globenewswire.com/media/d8cb3e79-0641-4cca-8687-15281f1437be/small/mereo-logo-full-colour-rgb-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225454-harvard-bioscience-announces-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-12T11:30:00+00:00 Harvard Bioscience Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/6784a4a6-c259-489c-8b5b-05266f41b06f/small/hbio-logo-png.png https://www.delawarehealthnewsonline.com/article/912225458-briacell-phase-3-bria-imt-study-enrollment-surpasses-230-patients Delaware Health News Online en PressRelease 2026-05-12T11:30:00+00:00 BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients https://ml.globenewswire.com/media/88b9408d-31d4-4afd-beff-f855719a15d8/small/briacell-logo-square-a-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225557-bridgebio-submits-nda-to-fda-for-encaleret-for-individuals-living-with-adh1 Delaware Health News Online en PressRelease 2026-05-12T11:30:00+00:00 BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1 https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.delawarehealthnewsonline.com/article/912225573-vireo-growth-inc-announces-first-quarter-2026-results Delaware Health News Online en PressRelease 2026-05-12T11:30:00+00:00 Vireo Growth Inc. Announces First Quarter 2026 Results https://ml.globenewswire.com/media/d01c0dca-8260-48c8-8ead-e09111cf57b5/small/vireo-horizontalllogolockup-01-png.png https://www.delawarehealthnewsonline.com/article/912225583-xilio-therapeutics-reports-first-quarter-2026-financial-results-and-provides-pipeline-and-business-updates Delaware Health News Online en PressRelease 2026-05-12T11:30:00+00:00 Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png https://www.delawarehealthnewsonline.com/article/912225309-neuraxis-reports-record-first-quarter-2026-financial-results-driven-by-80-year-over-year-revenue-growth Delaware Health News Online en PressRelease 2026-05-12T11:05:00+00:00 NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth https://ml.globenewswire.com/media/a1e3887d-3378-46c5-938d-2b0d5a7c825f/small/neuraxis-logo-png.png https://www.delawarehealthnewsonline.com/article/912225617-achieve-life-sciences-strengthens-board-and-commercial-leadership-with-three-senior-appointments-from-team-previously-at-verona-pharma Delaware Health News Online en PressRelease 2026-05-12T11:05:00+00:00 Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma https://ml.globenewswire.com/media/1026e030-275c-4391-8f9a-65c5c1ec7b88/small/achieve-logo-717x800px-2-1-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225676-arvinas-reports-first-quarter-2026-financial-results-and-provides-corporate-update Delaware Health News Online en PressRelease 2026-05-12T11:05:00+00:00 Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/563780a0-f8d9-4e37-8665-b622ef2caa5b/small/arvinas-logoart-lg-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225336-corvel-corporation-to-host-live-earnings-release-webcast Delaware Health News Online en PressRelease 2026-05-12T11:02:00+00:00 CorVel Corporation to Host Live Earnings Release Webcast https://ml.globenewswire.com/media/dc150059-2d36-47de-9f10-e6f5990ba046/small/corvel-primary-full-color-png.png https://www.delawarehealthnewsonline.com/article/912225324-prelude-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Delaware Health News Online en PressRelease 2026-05-12T11:01:00+00:00 Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/cab62748-b61a-42cb-b552-b0c6c91c4e83/small/ptx-logo-png.png https://www.delawarehealthnewsonline.com/article/912225276-proqr-announces-first-quarter-2026-operating-and-financial-results Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 ProQR Announces First Quarter 2026 Operating and Financial Results https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png https://www.delawarehealthnewsonline.com/article/912225279-ac-immune-announces-retirement-of-ceo-dr-andrea-pfeifer-at-upcoming-agm Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225282-immatics-announces-first-quarter-2026-financial-results-and-business-update Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Immatics Announces First Quarter 2026 Financial Results and Business Update https://ml-eu.globenewswire.com/media/1ef1cd0c-384c-4889-82c8-58bd42054fb8/small/immatics-final-logo-r-white-background-png.png https://www.delawarehealthnewsonline.com/article/912225288-novabridge-to-present-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference https://ml.globenewswire.com/media/0ea9f005-c7f7-4272-a3ac-cbf4ea4aef15/small/novabridge-logo-en-rgb-png.png https://www.delawarehealthnewsonline.com/article/912225294-sionna-therapeutics-reports-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Sionna Therapeutics Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png https://www.delawarehealthnewsonline.com/article/912225307-legend-biotech-reports-first-quarter-2026-results-and-recent-highlights Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Legend Biotech Reports First Quarter 2026 Results and Recent Highlights https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png https://www.delawarehealthnewsonline.com/article/912225344-foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-may Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225346-arbor-biotechnologies-achieves-unprecedented-precise-in-vivo-reverse-transcriptase-editing-in-the-brain-using-a-single-aav-vector-opening-a-new-path Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Arbor Biotechnologies Achieves Unprecedented Precise In Vivo Reverse Transcriptase Editing in the Brain Using a Single AAV Vector, Opening a New Path to Treatments for Neurological Diseases https://ml.globenewswire.com/media/68842426-d5ae-4dd2-800a-89d80ad4b3b7/small/arbor-biotech-logo-web-3-1-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225350-tenax-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225358-cartesian-therapeutics-to-participate-in-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png https://www.delawarehealthnewsonline.com/article/912225364-acumen-pharmaceuticals-reports-first-quarter-2026-financial-results-and-business-highlights Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png https://www.delawarehealthnewsonline.com/article/912225390-olema-oncology-reports-first-quarter-2026-financial-and-operating-results Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Olema Oncology Reports First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://www.delawarehealthnewsonline.com/article/912225403-seres-therapeutics-to-participate-in-h-c-wainwright-4th-annual-bioconnect-investor-conference Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png https://www.delawarehealthnewsonline.com/article/912225448-opus-genetics-announces-financial-results-for-first-quarter-2026-and-provides-corporate-update Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Opus Genetics Announces Financial Results for First Quarter 2026 and Provides Corporate Update https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225450-blue-point-brewing-launches-magic-hour-ipa-a-bright-tropical-6-abv-sipper-for-golden-hour Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Blue Point Brewing Launches Magic Hour IPA—A Bright, Tropical 6% ABV Sipper for Golden Hour https://ml.globenewswire.com/media/aad05a49-5280-4153-9183-4a388fff0fcc/medium/blue-point-magic-hour.jpeg https://www.delawarehealthnewsonline.com/article/912225520-medicenna-and-fondazione-melanoma-onlus-announce-first-patient-dosed-in-the-neo-cyt-study-of-mdna11-in-neoadjuvant-melanoma Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png https://www.delawarehealthnewsonline.com/article/912225577-c4-therapeutics-reports-first-quarter-2026-financial-results-and-recent-business-highlights Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/50045422-c7cb-42b0-857a-1f69f1efc0a6/small/c4therapeutics-website-logo-fullcolor-r-png.png https://www.delawarehealthnewsonline.com/article/912225615-achieve-life-sciences-reports-first-quarter-2026-financial-results-and-provides-business-updates Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/1026e030-275c-4391-8f9a-65c5c1ec7b88/small/achieve-logo-717x800px-2-1-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225625-ovid-therapeutics-reports-business-updates-and-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results https://ml.globenewswire.com/media/683042b5-bcb5-4ce5-84d4-2fbe238479cb/small/ovid-registered-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225655-felix-health-to-lower-semaglutide-pricing-by-up-to-65-as-lower-cost-options-enter-canada Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Felix Health to Lower Semaglutide Pricing by Up to 65% as Lower-Cost Options Enter Canada https://ml.globenewswire.com/media/34f01f28-be97-40ad-8a49-b70850fe9f7d/small/orange-png.png https://www.delawarehealthnewsonline.com/article/912225672-arvinas-and-pfizer-enter-into-a-transaction-with-rigel-pharmaceuticals-for-the-exclusive-global-rights-of-veppanu-vepdegestrant Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant) https://ml.globenewswire.com/media/563780a0-f8d9-4e37-8665-b622ef2caa5b/small/arvinas-logoart-lg-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225749-climb-bio-to-present-at-upcoming-investor-conferences Delaware Health News Online en PressRelease 2026-05-12T11:00:00+00:00 Climb Bio to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg https://www.delawarehealthnewsonline.com/article/912225600-promis-neurosciences-announces-first-quarter-2026-financial-results-and-provides-corporate-highlights Delaware Health News Online en PressRelease 2026-05-12T10:30:00+00:00 ProMIS Neurosciences Announces First Quarter 2026 Financial Results and Provides Corporate Highlights https://ml.globenewswire.com/media/26bec3c9-ac4b-487b-ab90-3b62be29497d/small/promis-jpg.jpg https://www.delawarehealthnewsonline.com/article/912207091-75-years-of-care-leading-chinese-women-s-hospital-innovating-for-women-children-worldwide Delaware Health News Online en PressRelease 2026-05-12T10:03:14+00:00 75 Years of Care: Leading Chinese Women's Hospital Innovating for Women, Children Worldwide https://ml.globenewswire.com/Resource/Download/d349948a-0f24-4ccc-9e7c-140813f07c2d/hospital.jpg https://www.delawarehealthnewsonline.com/article/912206955-addition-therapeutics-presents-preclinical-proof-of-concept-data-at-american-society-of-gene-cell-therapy-asgct-29th-annual-meeting Delaware Health News Online en PressRelease 2026-05-12T10:00:00+00:00 Addition Therapeutics Presents Preclinical Proof-of-Concept Data at American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting https://ml.globenewswire.com/media/3f8d8448-ab3a-452a-be14-dfe5bcca35f1/small/addition-th-logo-white-bg-gnw-png.png https://www.delawarehealthnewsonline.com/article/912192662-ektah-shows-50-reduction-in-post-glp-1-weight-rebound-with-novel-obesity-treatment-and-reports-positive-phase-i-data Delaware Health News Online en PressRelease 2026-05-12T08:00:00+00:00 EktaH Shows ~50% Reduction in Post-GLP-1 Weight Rebound with Novel Obesity Treatment and Reports Positive Phase I Data https://ml-eu.globenewswire.com/media/Y2QzY2VmMTMtNzNhNy00MGVkLWEwODgtZWMyNWEzZWMwNmJhLTEwMzc0NTQtMjAyNi0wNS0xMi1lbg==/tiny/AKAMPION.png https://www.delawarehealthnewsonline.com/article/912192664-astronautx-builds-executive-team-with-appointment-of-experienced-clinical-development-leader-michelle-mellion-md-as-chief-medical-officer Delaware Health News Online en PressRelease 2026-05-12T07:30:00+00:00 AstronauTx builds executive team with appointment of experienced clinical development leader Michelle Mellion, MD as Chief Medical Officer https://ml-eu.globenewswire.com/media/6e0a0d3c-d1a9-45de-82e7-1178a2900024/small/astronautx-logo-rgb-png.png https://www.delawarehealthnewsonline.com/article/912192666-vicentra-announces-commercial-launch-of-new-smartphone-controlled-kaleido-automated-insulin-delivery-patch-pump-system Delaware Health News Online en PressRelease 2026-05-12T07:30:00+00:00 ViCentra Announces Commercial Launch of New Smartphone-Controlled Kaleido Automated Insulin Delivery Patch Pump System https://ml-eu.globenewswire.com/media/97cc2ebe-8f0d-4051-aca4-6350b6043071/small/vicentra-logo-png.png https://www.delawarehealthnewsonline.com/article/912192670-orion-animal-health-receives-us-fda-approval-for-tessie-tasipimidine-oral-solution-for-the-treatment-of-noise-aversion-and-separation-anxiety-in Delaware Health News Online en PressRelease 2026-05-12T07:30:00+00:00 Orion Animal Health receives US FDA approval for Tessie® (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg https://www.delawarehealthnewsonline.com/article/912192673-orion-animal-health-sai-fda-lta-myyntiluvan-tessie-tuotteelle-tasipimidiini-oraaliliuos Delaware Health News Online en PressRelease 2026-05-12T07:30:00+00:00 Orion Animal Health sai FDA:lta myyntiluvan Tessie®-tuotteelle (tasipimidiini oraaliliuos) https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/ https://www.delawarehealthnewsonline.com/article/912177621-enterome-presents-phase-2-indolent-non-hodgkin-lymphoma-data-at-eha-showing-eo2463-induces-b-cell-target-specific-cd8-t-cell-expansion-correlating Delaware Health News Online en PressRelease 2026-05-12T06:30:00+00:00 Enterome presents Phase 2 indolent non-Hodgkin lymphoma data at EHA showing EO2463 induces B cell target-specific CD8 T-cell expansion correlating with clinical outcomes https://ml-eu.globenewswire.com/media/e04b919f-9b3c-4d80-af54-707d3fa48216/small/enterome-logo-png.png https://www.delawarehealthnewsonline.com/article/912177603-infex-therapeutics-secures-4-3-million-funding-to-advance-anti-infective-pipeline-targeting-drug-resistant-infections Delaware Health News Online en PressRelease 2026-05-12T06:00:00+00:00 Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections https://ml-eu.globenewswire.com/media/7e6719ab-feb1-4eb3-93c1-acca0cc4a3a1/small/infex-logo-png.png https://www.delawarehealthnewsonline.com/article/912143856-rapid-nutrition-extends-ai-powered-agentic-platform-to-consumer-ecosystem-following-investor-rollout Delaware Health News Online en PressRelease 2026-05-12T03:00:00+00:00 Rapid Nutrition Extends AI-Powered Agentic Platform to Consumer Ecosystem Following Investor Rollout https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://www.delawarehealthnewsonline.com/article/912126150-gala-health-glp-1-compounded-and-branded-weight-loss-medication-options-with-real-doctor-support Delaware Health News Online en PressRelease 2026-05-12T01:53:35+00:00 Gala Health GLP-1 Compounded and Branded Weight Loss Medication Options with Real Doctor Support https://zingfast.com/wp-content/uploads/2026/05/Gala-Health-GLP-1-Compounded-and-Branded-Weight-Loss-Medication-Options-with-Real-Doctor-Support.jpg https://www.delawarehealthnewsonline.com/article/912126135-enlitic-s-ensight-goes-live-at-rhcnz-advancing-radiology-workflow-efficiency-in-new-zealand Delaware Health News Online en PressRelease 2026-05-12T01:32:44+00:00 Enlitic’s Ensight Goes Live at RHCNZ, Advancing Radiology Workflow Efficiency in New Zealand https://ml.globenewswire.com/media/998557dc-9a0b-48b9-bfbc-579da6b75660/medium/enlitics-ensight-goes-live-at-rhcnz.jpg https://www.delawarehealthnewsonline.com/article/911377449-alanda-software-launches-next-generation-commercial-compliance-suite-for-life-sciences Delaware Health News Online en PressRelease 2026-05-11T12:45:00+00:00 Alanda Software Launches Next-Generation Commercial Compliance Suite for Life Sciences https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850424-alanda-logo-1298x231.png https://www.delawarehealthnewsonline.com/article/912106868-delos-capital-and-ap-biosciences-inc-launch-collaboration-to-create-new-biotech-companies-focused-on-next-generation-antibodies Delaware Health News Online en PressRelease 2026-05-12T00:00:00+00:00 Delos Capital and AP Biosciences Inc. Launch Collaboration to Create New Biotech Companies Focused on Next-Generation Antibodies https://ml.globenewswire.com/media/92753de3-30bd-49fa-bc78-264699195351/small/logo-png.png https://www.delawarehealthnewsonline.com/article/912071498-macrogenics-to-sell-gmp-manufacturing-operations-to-bora-pharmaceuticals Delaware Health News Online en PressRelease 2026-05-11T21:20:43+00:00 MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png https://www.delawarehealthnewsonline.com/article/912071488-biocardia-to-host-q1-2026-financial-results-and-corporate-update-conference-call-on-may-15-2026 Delaware Health News Online en PressRelease 2026-05-11T21:10:39+00:00 BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026 https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://www.delawarehealthnewsonline.com/article/912071358-correction-human-appeal-launches-hajj-step-challenge-turning-steps-into-a-lifeline Delaware Health News Online en PressRelease 2026-05-11T21:04:51+00:00 CORRECTION – Human Appeal Launches Hajj Step Challenge, Turning Steps into a Lifeline https://ml-eu.globenewswire.com/media/6d57b095-4239-423a-bc6a-62d104c91ba8/small/human-appeal-logo-440-jpg.jpg https://www.delawarehealthnewsonline.com/article/912071471-biomea-fusion-reports-first-quarter-2026-financial-results-and-corporate-highlights Delaware Health News Online en PressRelease 2026-05-11T20:54:51+00:00 Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights https://ml.globenewswire.com/media/d2f051eb-da8d-4233-9093-8ff1579d035f/small/biomea-fusion-logo-rgb-rev2-email-png.png https://www.delawarehealthnewsonline.com/article/912071458-sanara-medtech-inc-reports-first-quarter-2026-financial-results-unaudited Delaware Health News Online en PressRelease 2026-05-11T20:50:00+00:00 Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited) https://ml.globenewswire.com/media/591eb30b-d3e4-428c-9cd6-536215925b01/small/logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912056025-sotera-health-announces-secondary-offering-of-common-stock Delaware Health News Online en PressRelease 2026-05-11T20:33:27+00:00 Sotera Health Announces Secondary Offering of Common Stock https://ml.globenewswire.com/media/a0ec722c-ad65-4f05-a8ae-bc1aa6cc4db4/small/sotera-png.png https://www.delawarehealthnewsonline.com/article/912055557-tonix-pharmaceuticals-reports-first-quarter-2026-financial-results-and-operational-highlights Delaware Health News Online en PressRelease 2026-05-11T20:30:00+00:00 Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://www.delawarehealthnewsonline.com/article/912055813-steris-announces-financial-results-for-fiscal-2026-fourth-quarter-and-full-year Delaware Health News Online en PressRelease 2026-05-11T20:30:00+00:00 STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year https://ml.globenewswire.com/media/2c1a9c6d-bc94-4d3f-a47f-0ac0d209f8b6/small/sterishoriz-no-r-rgb-jpg-jpg.jpg https://www.delawarehealthnewsonline.com/article/912055909-cellectis-reports-financial-results-for-the-first-quarter-2026 Delaware Health News Online en PressRelease 2026-05-11T20:30:00+00:00 Cellectis Reports Financial Results for the First Quarter 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.delawarehealthnewsonline.com/article/912055924-cellectis-publie-ses-r-sultats-financiers-du-premier-trimestre-2026 Delaware Health News Online en PressRelease 2026-05-11T20:30:00+00:00 Cellectis publie ses résultats financiers du premier trimestre 2026 https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png https://www.delawarehealthnewsonline.com/article/912055999-scynexis-reports-first-quarter-2026-financial-results-and-provides-corporate-update Delaware Health News Online en PressRelease 2026-05-11T20:23:30+00:00 SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/4171e010-3103-4d21-b1c5-5b1c27927dce/small/scyxprimarysmall-png.png https://www.delawarehealthnewsonline.com/article/912055968-fda-advances-drug-repurposing-to-address-unmet-medical-needs Delaware Health News Online en PressRelease 2026-05-11T20:17:32+00:00 FDA Advances Drug Repurposing to Address Unmet Medical Needs https://ml.globenewswire.com/media/YzZiZmY2MzEtODkxYS00MGY1LWFlOTEtOTVhMGY2MWU5NjQyLTUwMDE1NDE1NC0yMDI2LTA1LTExLWVu/tiny/FDA.png https://www.delawarehealthnewsonline.com/article/912055947-solana-company-to-release-first-quarter-2026-operating-results-on-may-15-2026 Delaware Health News Online en PressRelease 2026-05-11T20:16:12+00:00 Solana Company to Release First Quarter 2026 Operating Results on May 15, 2026 https://ml.globenewswire.com/media/1986b97e-8656-4213-9218-ae51324d696d/small/solana-company-main-black-png.png https://www.delawarehealthnewsonline.com/article/912055352-cg-oncology-s-presence-at-american-urological-association-aua-annual-meeting-underscores-its-strong-commitment-to-nmibc Delaware Health News Online en PressRelease 2026-05-11T20:15:00+00:00 CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC https://ml.globenewswire.com/media/9e1cbdea-928e-4ea4-b4cd-33cdc36c6b2f/small/cgoncology-cover-jpg.jpg https://www.delawarehealthnewsonline.com/article/912055548-pharvaris-announces-closing-of-132-3-million-underwritten-offering-of-ordinary-shares-and-full-exercise-of-underwriters-option-to-purchase Delaware Health News Online en PressRelease 2026-05-11T20:15:00+00:00 Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://www.delawarehealthnewsonline.com/article/912055902-catalyst-pharmaceuticals-reports-first-quarter-2026-financial-results Delaware Health News Online en PressRelease 2026-05-11T20:12:45+00:00 Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg https://www.delawarehealthnewsonline.com/article/912055278-si-bone-inc-reports-financial-results-for-the-first-quarter-2026-and-raises-2026-guidance Delaware Health News Online en PressRelease 2026-05-11T20:09:00+00:00 SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance https://ml.globenewswire.com/media/1630843d-d109-4819-9c6f-455c684690ba/small/sibn-logo-jpg.jpg https://www.delawarehealthnewsonline.com/article/912054638-oculis-reports-q1-2026-financial-results-and-provides-company-update Delaware Health News Online en PressRelease 2026-05-11T20:07:00+00:00 Oculis Reports Q1 2026 Financial Results and Provides Company Update https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://www.delawarehealthnewsonline.com/article/912054640-abivax-announces-results-of-its-may-11-2026-annual-general-meeting Delaware Health News Online en PressRelease 2026-05-11T20:05:00+00:00 Abivax Announces Results of its May 11, 2026 Annual General Meeting https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png https://www.delawarehealthnewsonline.com/article/912054689-outset-medical-to-present-at-rbc-global-healthcare-conference Delaware Health News Online en PressRelease 2026-05-11T20:05:00+00:00 Outset Medical to Present at RBC Global Healthcare Conference https://ml.globenewswire.com/media/28778c78-03f1-4b17-9c13-3cc578c924dc/small/outset-id-orangegrey-png.png https://www.delawarehealthnewsonline.com/article/912054998-cvrx-reports-first-quarter-2026-financial-and-operating-results Delaware Health News Online en PressRelease 2026-05-11T20:05:00+00:00 CVRx Reports First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png